衰弱对经导管主动脉瓣植入术后1年健康相关生活质量的影响
该前瞻性观察研究纳入239例接受TAVI并完成1年HRQoL评估的患者,用Erasmus衰弱评分判定衰弱,用EQ-5D-5L评估HRQoL。结果显示衰弱是TAVI后1年HRQoL恶化的独立预测因素(OR 2.24,95%CI 1.07-4.70,P=0.003);基线无外周动脉疾病或肾功能不全的衰弱患者HRQoL反而改善。
要点
- 衰弱是TAVI后1年HRQoL恶化的独立预测因素(OR 2.24)。
- 非衰弱患者EQ-5D-5L指数1年前后无显著变化(P=0.22)。
- 衰弱患者基线无外周动脉疾病或肾功能不全者HRQoL可改善。
核心结论
- 衰弱与TAVI后1年健康相关生活质量恶化相关。
- 基线无外周动脉疾病或肾功能不全的衰弱患者,TAVI后1年HRQoL反而改善。
研究设计与样本
- TAVI Care & Cure Program为正在进行的、前瞻性、观察性研究,纳入转诊至本机构接受TAVI的患者。
- 采用老年综合评估,以Erasmus衰弱评分(EFS)判定衰弱。
- 以EQ-5D-5L评估基线及TAVI后1年HRQoL。
- 239例患者接受TAVI并完成1年HRQoL评估。
主要发现
- 70例(29.3%)被判定为衰弱(EFS ≥ 3)。
- 非衰弱患者EQ-5D-5L指数由0.71(±0.22)变为0.68(±0.33)分,P = 0.22。
- 衰弱患者EQ-5D-5L指数由0.55(±0.26)降至0.44(±0.33)分,P = 0.022。
- 衰弱是TAVI后1年HRQoL恶化的独立预测因素(OR 2.24,95% CI 1.07-4.70,P = 0.003)。
- 衰弱患者基线无外周动脉疾病(OR 0.17,95% CI 0.05-0.50,P = 0.001)及无肾功能不全(OR 0.13,95% CI 0.04-0.41,P = <0.001)与TAVI后1年HRQoL改善相关。
关键数值与推荐
- 衰弱判定标准为Erasmus衰弱评分(EFS)≥ 3。
- HRQoL评估工具为EQ-5D-5L指数。
- 衰弱预测HRQoL恶化的OR为2.24(95% CI 1.07-4.70,P = 0.003)。
- 衰弱患者基线无外周动脉疾病的OR为0.17(95% CI 0.05-0.50,P = 0.001)。
- 衰弱患者基线无肾功能不全的OR为0.13(95% CI 0.04-0.41,P = <0.001)。
临床怎么用
- 对拟行TAVI的老年患者应行老年综合评估并以EFS识别衰弱。
- 对衰弱患者应告知TAVI后1年HRQoL可能恶化,并评估基线外周动脉疾病与肾功能以辅助预后判断。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transcatheter aortic valve implantation (TAVI) brings symptom relief and improvement in health-related quality of life (HRQoL) in the majority of patients treated for symptomatic, severe aortic stenosis. However, there is a substantial group of patients that do not benefit from TAVI. The aim of this study is to investigate the impact of frailty on HRQoL 1 year after TAVI. METHODS: The TAVI Care & Cure Program is an ongoing, prospective, observational study including patients referred for TAVI to our institution. A comprehensive geriatric assessment was performed to evaluate existence of frailty using the Erasmus Frailty Score (EFS). HRQoL was assessed using the EQ-5D-5 L at baseline and 1 year after TAVI. RESULTS: 239 patients underwent TAVI and completed HRQoL assessment 1 year after TAVI. Seventy (29.3%) patients were classified as frail (EFS ≥ 3). In non-frail patients, the EQ-5D-5 L index did not change (0.71(± 0.22) to 0.68(± 0.33) points, P = 0.22); in frail patients, the EQ-5D-5 L index decreased from 0.55(±0.26) to 0.44 points (±0.33) (P = 0.022). Frailty was an independent predictor of deteriorated HRQoL 1 year after TAVI (OR 2.24, 95% CI 1.07-4.70, P = 0.003). In frail patients, the absence of peripheral artery disease (OR 0.17, 95% 0.05-0.50, P = 0.001) and renal dysfunction (OR 0.13, 95% CI 0.04-0.41, P = <0.001) at baseline was associated with improved HRQoL 1 year after TAVI. CONCLUSION: Frailty is associated with deterioration of HRQoL 1 year after TAVI. Notably, HRQoL did improve in frail patients with no peripheral arterial disease or renal impairment at baseline.
引用
- Goudzwaard JA, de Ronde-Tillmans MJAG, van Hoorn FED, et al. Impact of frailty on health-related quality of life 1 year after transcatheter aortic valve implantation. Age Ageing. 2020. PMID: 32421189. doi:10.1093/ageing/afaa071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。